HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2003
11701	11701 Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, et al. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (2): 57-63	13	30	4	33
11702	11702 Zekanowski C, Peplonska B, Styczynska M, Gustaw K, Kuznicki J, et al. Mutation screening of the MAPT and STH genes in polish patients with clinically diagnosed frontotemporal dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (3): 126-131	10	10	17	28
11703	11703 Combarros O, Rodero L, Infante J, Palacio E, Llorca J, et al. Age-dependent association between the Q7R polymorphism in the saitohin gene and sporadic Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (3): 132-135	6	10	14	26
11704	11704 Jarvenpaa T, Raiha I, Kaprio J, Koskenvuo M, Laine M, et al. Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (4): 245-252	0	10	2	41
11705	11705 Ibach B, Koch H, Koller M, Wolfersdorf M Hospital admission circumstances and prevalence of frontotemporal lobar degeneration: a multicenter psychiatric state hospital study in Germany DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (4): 253-264	3	10	8	59
11706	11706 Mor M, Spadoni G, Diamantini G, Bedini A, Tarzia G, et al. Antioxidant and cytoprotective activity of indole derivatives related to melatonin DEVELOPMENTS IN TRYPTOPHAN AND SEROTONIN METABOLISM. 2003; 527: 567-575	0	4	1	25
11707	11707 Dib M Amyotrophic lateral sclerosis - Progress and prospects for treatment DRUGS. 2003; 63 (3): 289-310	2	14	42	272
11708	11708 Cooper JL Dietary lipids in the aetiology of Alzheimer's disease - Implications for therapy DRUGS & AGING. 2003; 20 (6): 399-418	2	10	27	258
11709	11709 Litt B Evaluating devices for treating epilepsy EPILEPSIA. 2003; 44: 30-37	0	8	1	55
11710	11710 Lhatoo SD, Perunovic B, Love S, Houlden H, Campbell MJ Familial idiopathic brain calcification - A new and familial alpha- synucleinopathy? EUROPEAN NEUROLOGY. 2003; 49 (4): 223-226	0	8	5	14
#	Date / Author / Journal	LCS	GCS	LCR	CR
11711	11711 Kowalska A, Konagaya M, Sakai M, Hashizume Y, Tabira T Familial amyotrophic lateral sclerosis and parkinsonism-d dementia complex - tauopathy without mutations in the tau gene? FOLIA NEUROPATHOLOGICA. 2003; 41 (2): 59-64	6	8	9	20
11712	11712 Bertrand E, Lechowicz W, Lewandowska E, Szpak G, Dymecki J, et al. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease FOLIA NEUROPATHOLOGICA. 2003; 41 (4): 197-207	5	13	10	31
11713	11713 Stolzing A, Grune T Protein aggregates and the development of neurodegenerative diseases FREE RADICALS, NITRIC OXIDE, AND INFLAMMATION: MOLECULAR, BIOCHEMICAL, AND CLINICAL ASPECTS. 2003; 344: 170-181	0	1	15	83
11714	11714 Matoh N, Tanaka S, Takehashi M, Banasik M, Stedeford T, et al. Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells GENE EXPRESSION. 2003; 11 (3-4): 117-124	0	5	1	33
11715	11715 Griffin RS, Mills CD, Costigan M, Woolf CJ Exploiting microarrays to reveal differential gene expression in the nervous system GENOME BIOLOGY. 2003; 4 (2): Art. No. 105	2	11	4	32
11716	11716 Lee A, Thompson L, O'Rourke JL Priorities for future research: microbiology HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002. 2003; : 515-522	0	0	2	42
11717	11717 Lopez-Picon FR, Uusi-Oukari M, Holopainen IE Differential expression and localization of the phosphorylated and nonphosphorylated neurofilaments during the early postnatal development of rat hippocampus HIPPOCAMPUS. 2003; 13 (7): 767-779	6	16	19	39
11718	11718 Schallert T, Woodlee MT, Fleming SM Experimental focal ischemic injury: Behavior-brain interactions and issues of animal handling and housing ILAR JOURNAL. 2003; 44 (2): 130-143	1	11	4	205
11719	11719 Wallin A, Milos V, Sjogren M, Pantoni L, Erkinjuntti T Classification and subtypes of vascular dementia INTERNATIONAL PSYCHOGERIATRICS. 2003; 15: 27-37	1	6	3	48
11720	11720 Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 223. 2003; 223: 83-+	3	104	35	439
#	Date / Author / Journal	LCS	GCS	LCR	CR
11721	11721 Sugaya K Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 228. 2003; 228: 1-30	0	23	25	137
11722	11722 Spillantini MG Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 27TH SESSION. 2003; : 647-659	0	0	48	55
11723	11723 Aigaki T, Kaneuchi T, Matsuo T, Seong KH, Togawa T Genetic bases of oxidative stress resistance and life span in Drosophila JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2003; 34 (2): 77-83	0	3	4	43
11724	11724 Tsai HF, Liu CS, Chen GD, Lin ML, Li C, et al. Prenatal diagnosis of Machado-Joseph disease Spinocerebellar Ataxia Type 3 in Taiwan: Early detection of expanded ataxin-3 JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2003; 17 (5): 195-200	1	1	4	30
11725	11725 Mruthinti S, Hill WD, Swamy-Mruthinti S, Buccafusco JJ Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 223-232	0	6	8	38
11726	11726 Kung MP, Zhuang ZP, Hou C, Jin LW, Kung HF Characterization of radioiodinated ligand binding to amyloid beta plaques JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 249-253	9	9	5	5
11727	11727 Wang YM, Mathis CA, Huang GF, Debnath ML, Holt DP, et al. Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 255-260	12	21	11	23
11728	11728 Marques MA, Crutcher KA Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 327-337	3	13	8	103
11729	11729 Iqbal K, Alonso AD, El-Akkad E, Gong CX, Haque N, et al. Alzheimer neurofibrillary degeneration - Therapeutic targets and high- throughput assays JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 425-429	6	21	19	45
11730	11730 Gilgun-Sherki Y, Melamed E, Offen D Antioxidant treatment in Alzheimer's disease - Current state JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 21 (1): 1-11	3	28	13	58
#	Date / Author / Journal	LCS	GCS	LCR	CR
11731	11731 Levy YS, Merims D, Panet H, Barhum Y, Melamed E, et al. Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 21 (2): 121-132	7	27	9	50
11732	11732 Pan WH, Csernus B, Kastin AJ Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 21 (2): 173-184	0	21	4	43
11733	11733 Tolosa E Advances in the pharmacological management of Parkinson disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (64): 65-78	2	4	2	101
11734	11734 Youdim MBH What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease? JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 73-88	10	16	10	80
11735	11735 Jellinger KA General aspects of neurodegeneration JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 101-144	12	37	89	198
11736	11736 Bosboom JLW, Stoffers D, Wolters EC The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 185-195	0	9	3	62
11737	11737 Watts RL, Raiser CD, Stover NP, Cornfeldt ML, Schweikert AW, et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 215-227	16	32	5	48
11738	11738 Ciccotosto GD, Barnham KJ, Cherny RA, Masters CL, Bush AI, et al. Methionine oxidation: Implications for the mechanism of toxicity of the beta-amyloid peptide from Alzheimer's disease LETTERS IN PEPTIDE SCIENCE. 2003; 10 (5-6): 413-417	0	8	10	43
11739	11739 Fossella JA, Sommer T, Fan J, Pfaff D, Posner MI Synaptogenesis and heritable aspects of executive attention MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2003; 9 (3): 178-183	1	6	6	85
11740	11740 Mori H, Kosaka S, Arawaka S, Tomiyama T Distinct functions of tau isoforms in Alzheimer's disease MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 347-354	0	0	11	21
#	Date / Author / Journal	LCS	GCS	LCR	CR
11741	11741 Murakami T, Kawarabayashi T, Matsubara E, Shoji M, Abe K Molecular pathology of transgenic tau mice MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 379-382	0	0	7	8
11742	11742 Dou F, Netzer WJ, Takashima A, Xu HX Heat shock proteins reduce aggregation and facilitate degradation of tau protein MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 383-393	1	3	9	18
11743	11743 Matsubara E, Shoji M, Murakami T, Kawarabayashi T, Abe K Alzheimer's disease and melatonin MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 395-398	1	5	3	34
11744	11744 Chopp M, Li Y Treatment of stroke with marrow stromal cells MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 465-470	0	1	7	40
11745	11745 Song SM, Jung YK Ubiquitin and intracellular aggregation - A common pathway of neurodegeneration in chronic dementia? MOLECULAR MECHANISMS OF PROGRAMMED CELL DEATH. 2003; : 185-193	0	0	17	44
11746	11746 Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, et al. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias MOLECULAR PSYCHIATRY. 2003; 8 (3): 343-347	32	55	11	20
11747	11747 Chesselet MF Dopamine and Parkinson's disease: is the killer in the house? MOLECULAR PSYCHIATRY. 2003; 8 (4): 369-370	2	4	8	12
11748	11748 Sweet RA, Nimponkar VL, Devlin B, Jeste DV Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype MOLECULAR PSYCHIATRY. 2003; 8 (4): 383-392	2	41	7	104
11749	11749 Hol EM, Roelofs RF, Moraal E, Sonnemans MAF, Sluijs JA, et al. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms MOLECULAR PSYCHIATRY. 2003; 8 (9): 786-796	8	37	8	45
11750	11750 Jellinger KA Neuropathological spectrum of synucleinopathies MOVEMENT DISORDERS. 2003; 18: S2-S12	45	64	45	75
#	Date / Author / Journal	LCS	GCS	LCR	CR
11751	11751 Revesz T, Holton JL Anatamopathological spectrum of tauopathies MOVEMENT DISORDERS. 2003; 18: S13-S20	0	3	36	69
11752	11752 Marti MJ, Tolosa E, Campdelacreu J Clinical overview of the synucleinopathies MOVEMENT DISORDERS. 2003; 18: S21-S27	16	22	6	43
11753	11753 Lees AJ Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings MOVEMENT DISORDERS. 2003; 18: S28-S33	2	2	19	53
11754	11754 Wenning GK, Geser F, Stampfer-Kountchev M, Tison F Multiple system atrophy: An update MOVEMENT DISORDERS. 2003; 18: S34-S42	6	24	28	74
11755	11755 Litvan I Update on epidemiological aspects of progressive supranuclear palsy MOVEMENT DISORDERS. 2003; 18: S43-S50	7	13	27	112
11756	11756 Kertesz A Pick's complex and FTDP-17 MOVEMENT DISORDERS. 2003; 18: S57-S62	9	9	19	62
11757	11757 Emre M What causes mental dysfunction in Parkinson's disease? MOVEMENT DISORDERS. 2003; 18: S63-S71	16	61	11	90
11758	11758 Uhl GR Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism MOVEMENT DISORDERS. 2003; 18: S71-S80	4	27	6	115
11759	11759 Burn DJ, McKeith IG Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease MOVEMENT DISORDERS. 2003; 18: S72-S79	14	32	9	74
11760	11760 Burn DJ, O'Brien JT Use of functional imaging in parkinsonism and dementia MOVEMENT DISORDERS. 2003; 18: S88-S95	6	14	7	64
#	Date / Author / Journal	LCS	GCS	LCR	CR
11761	11761 Snowden JS, Neary D Progressive anomia with preserved oral spelling and automatic speech NEUROCASE. 2003; 9 (1): 27-43	2	8	4	57
11762	11762 Cookson MR Parkin's substrates and the pathways leading to neuronal damage NEUROMOLECULAR MEDICINE. 2003; 3 (1): 1-13	11	28	26	69
11763	11763 Trojanowski JQ, Mattson MP Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 1-5	20	20	15	24
11764	11764 Hashimoto M, Rockenstein E, Crews L, Masliah E Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 21-35	28	88	64	108
11765	11765 Yancopoulou D, Spillantini MG Tau protein in familial and sporadic diseases NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 37-48	8	12	87	101
11766	11766 Giasson BI, Lee VMY, Trojanowski JQ Interactions of amyloidogenic proteins NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 49-58	26	26	54	88
11767	11767 Smith DH, Uryu K, Saatman KE, Trojanowski JQ, McIntosh TK Protein accumulation in traumatic brain injury NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 59-72	35	35	73	132
11768	11768 Moore DJ, Dawson VL, Dawson TM Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 95-108	12	26	62	98
11769	11769 Schindowski K, Kratzsch T, Peters J, Steiner B, Leutner S, et al. Impact of aging NEUROMOLECULAR MEDICINE. 2003; 4 (3): 161-177	2	20	14	55
11770	11770 Muller T, Voss B, Hellwig K, Przuntek H Treatment benefit correlates with increase of daily drug costs in Parkinson's disease clinics NEUROREHABILITATION. 2003; 18 (3): 271-275	0	7	1	17
#	Date / Author / Journal	LCS	GCS	LCR	CR
11771	11771 Copray JCVM, Jaarsma D, Kust BM, Bruggeman RWG, Mantingh I, et al. Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis NEUROSCIENCE. 2003; 116 (3): 685-694	2	20	8	54
11772	11772 Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM Lithium stimulates progenitor proliferation in cultured brain neurons NEUROSCIENCE. 2003; 117 (1): 55-61	3	44	2	35
11773	11773 Bussiere T, Gold G, Kovari E, Giannakopoulos P, Bouras C, et al. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease NEUROSCIENCE. 2003; 117 (3): 577-592	21	37	17	76
11774	11774 Zohar O, Schreiber S, Getslev V, Schwartz JP, Mullins PG, et al. Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice NEUROSCIENCE. 2003; 118 (4): 949-955	11	34	8	32
11775	11775 Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, et al. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra- hydropyridine-induced parkinsonism in mice NEUROSCIENCE. 2003; 118 (4): 985-1002	43	53	32	95
11776	11776 Sun L, Liu SY, Zhou XW, Wang XC, Liu R, et al. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats NEUROSCIENCE. 2003; 118 (4): 1175-1182	40	62	29	54
11777	11777 Wu A, Molteni R, Ying Z, Gomez-Pinilla F A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain- derived neurotrophic factor NEUROSCIENCE. 2003; 119 (2): 365-375	5	53	4	49
11778	11778 Van Groen T, Liu L, Ikonen S, Kadish I Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions NEUROSCIENCE. 2003; 119 (4): 1185-1197	4	21	21	70
11779	11779 Pieri M, Gaetti C, Spalloni A, Cavalcanti S, Mercuri N, et al. alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn superoxide dismutase (Gly(93) -> Ala) mutation NEUROSCIENCE. 2003; 122 (1): 47-58	4	20	1	61
11780	11780 Mirnics K, Middleton FA, Pierri JN, Lewis DA, Levitt P Analysis of brain disorders using DNA microarrays NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 45-63	0	0	21	131
#	Date / Author / Journal	LCS	GCS	LCR	CR
11781	11781 Botas J Neurodegenerative diseases: Insights from Drosophila and mouse models NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 85-103	0	0	65	106
11782	11782 Barkats M, Bemelmans A, Brun S, Corti O, Sarkis C, et al. Gene therapy in the central nervous system NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 173-186	0	0	6	54
11783	11783 Kesavapany S, Li BS, Pant HC Cyclin-dependent kinase 5 in neurofilament function and regulation NEUROSIGNALS. 2003; 12 (4-5): 252-264	6	21	47	87
11784	11784 Kheradpezhouh M, Shavali S, Ebadi M Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells NEUROSIGNALS. 2003; 12 (6): 315-324	2	14	12	51
11785	11785 Palomo T, Beninger RJ, Kostrzewa RM, Archer T Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations NEUROTOXICITY RESEARCH. 2003; 5 (1-2): 1-26	2	24	28	401
11786	11786 Asanuma M, Miyazaki I, Ogawa N Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease NEUROTOXICITY RESEARCH. 2003; 5 (3): 165-176	20	119	9	114
11787	11787 Andersen JK Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease NEUROTOXICITY RESEARCH. 2003; 5 (5): 307-313	2	22	19	86
11788	11788 Kazuko H, Manabu F, Hisayuki K, Shoji T, Fumiya O Park 8 - New locus for an autosomal dominant Japanese family NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS. 2003; : 97-106	0	0	9	27
11789	11789 MacDonald TJ, Rood BR, Santi MR, Vezina G, Bingaman K, et al. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors ONCOLOGIST. 2003; 8 (2): 174-186	13	36	12	63
11790	11790 Calne DB Parkinson's disease over the last 100 years PARKINSON'S DISEASE. 2003; 91: 1-8	1	2	12	48
#	Date / Author / Journal	LCS	GCS	LCR	CR
11791	11791 Przedborski T, Jackson-Lewis V, Vila M, Wu DC, Teismann P, et al. Free radical and nitric oxide toxicity in Parkinson's disease PARKINSON'S DISEASE. 2003; 91: 83-94	0	0	5	45
11792	11792 Gasser T Overview of the genetics of parkinsonism PARKINSON'S DISEASE. 2003; 91: 143-152	8	19	35	99
11793	11793 Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML Hereditary tauopathies and parkinsonism PARKINSON'S DISEASE. 2003; 91: 153-163	10	15	30	49
11794	11794 Golbe LI alpha-synuclein and Parkinson's disease PARKINSON'S DISEASE. 2003; 91: 165-174	7	9	66	93
11795	11795 Facca AG, Koller WC Differential diagnosis of parkinsonism PARKINSON'S DISEASE. 2003; 91: 383-396	1	4	26	133
11796	11796 Lim KL, Dawson VL, Dawson TM The cast of molecular characters in Parkinson's disease - Felons, conspirators, and suspects PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 80-92	8	16	42	59
11797	11797 Ischiropoulos H Oxidative modifications of alpha-synuclein PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 93-100	39	45	29	53
11798	11798 Trojanowski JQ, Lee VMY Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 107-110	60	60	11	13
11799	11799 Beal MF Mitochondria, oxidative damage, and inflammation in Parkinson's disease PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 120-131	45	206	4	115
11800	11800 Maguire-Zeiss KA, Federoff HJ Convergent pathobiologic model of Parkinson's disease PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 152-166	17	27	41	83

Date / Author / Journal

LCS

GCS

LCR

2003

11701

11701 Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, et al.

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (2): 57-63

11702

11702 Zekanowski C, Peplonska B, Styczynska M, Gustaw K, Kuznicki J, et al.

Mutation screening of the MAPT and STH genes in polish patients with clinically diagnosed frontotemporal dementia

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (3): 126-131

11703

11703 Combarros O, Rodero L, Infante J, Palacio E, Llorca J, et al.

Age-dependent association between the Q7R polymorphism in the saitohin gene and sporadic Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (3): 132-135

11704

11704 Jarvenpaa T, Raiha I, Kaprio J, Koskenvuo M, Laine M, et al.

Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (4): 245-252

11705

11705 Ibach B, Koch H, Koller M, Wolfersdorf M

Hospital admission circumstances and prevalence of frontotemporal lobar degeneration: a multicenter psychiatric state hospital study in Germany

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003; 16 (4): 253-264

11706

11706 Mor M, Spadoni G, Diamantini G, Bedini A, Tarzia G, et al.

Antioxidant and cytoprotective activity of indole derivatives related to melatonin

DEVELOPMENTS IN TRYPTOPHAN AND SEROTONIN METABOLISM. 2003; 527: 567-575

11707

11707 Dib M

Amyotrophic lateral sclerosis - Progress and prospects for treatment

DRUGS. 2003; 63 (3): 289-310

272

11708

11708 Cooper JL

Dietary lipids in the aetiology of Alzheimer's disease - Implications for therapy

DRUGS & AGING. 2003; 20 (6): 399-418

258

11709

11709 Litt B

Evaluating devices for treating epilepsy

EPILEPSIA. 2003; 44: 30-37

11710

11710 Lhatoo SD, Perunovic B, Love S, Houlden H, Campbell MJ

Familial idiopathic brain calcification - A new and familial alpha- synucleinopathy?

EUROPEAN NEUROLOGY. 2003; 49 (4): 223-226

Date / Author / Journal

LCS

GCS

LCR

11711

11711 Kowalska A, Konagaya M, Sakai M, Hashizume Y, Tabira T

Familial amyotrophic lateral sclerosis and parkinsonism-d dementia complex - tauopathy without mutations in the tau gene?

FOLIA NEUROPATHOLOGICA. 2003; 41 (2): 59-64

11712

11712 Bertrand E, Lechowicz W, Lewandowska E, Szpak G, Dymecki J, et al.

Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease

FOLIA NEUROPATHOLOGICA. 2003; 41 (4): 197-207

11713

11713 Stolzing A, Grune T

Protein aggregates and the development of neurodegenerative diseases

FREE RADICALS, NITRIC OXIDE, AND INFLAMMATION: MOLECULAR, BIOCHEMICAL, AND CLINICAL ASPECTS. 2003; 344: 170-181

11714

11714 Matoh N, Tanaka S, Takehashi M, Banasik M, Stedeford T, et al.

Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells

GENE EXPRESSION. 2003; 11 (3-4): 117-124

11715

11715 Griffin RS, Mills CD, Costigan M, Woolf CJ

Exploiting microarrays to reveal differential gene expression in the nervous system

GENOME BIOLOGY. 2003; 4 (2): Art. No. 105

11716

11716 Lee A, Thompson L, O'Rourke JL

Priorities for future research: microbiology

HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002. 2003; : 515-522

11717

11717 Lopez-Picon FR, Uusi-Oukari M, Holopainen IE

Differential expression and localization of the phosphorylated and nonphosphorylated neurofilaments during the early postnatal development of rat hippocampus

HIPPOCAMPUS. 2003; 13 (7): 767-779

11718

11718 Schallert T, Woodlee MT, Fleming SM

Experimental focal ischemic injury: Behavior-brain interactions and issues of animal handling and housing

ILAR JOURNAL. 2003; 44 (2): 130-143

205

11719

11719 Wallin A, Milos V, Sjogren M, Pantoni L, Erkinjuntti T

Classification and subtypes of vascular dementia

INTERNATIONAL PSYCHOGERIATRICS. 2003; 15: 27-37

11720

11720 Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM

Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 223. 2003; 223: 83-+

104

439

Date / Author / Journal

11721

Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 228. 2003; 228: 1-30

137

11722

11722 Spillantini MG

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17

INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 27TH SESSION. 2003; : 647-659

11723

11723 Aigaki T, Kaneuchi T, Matsuo T, Seong KH, Togawa T

Genetic bases of oxidative stress resistance and life span in Drosophila

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2003; 34 (2): 77-83

11724

11724 Tsai HF, Liu CS, Chen GD, Lin ML, Li C, et al.

Prenatal diagnosis of Machado-Joseph disease Spinocerebellar Ataxia Type 3 in Taiwan: Early detection of expanded ataxin-3

JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2003; 17 (5): 195-200

11725

11725 Mruthinti S, Hill WD, Swamy-Mruthinti S, Buccafusco JJ

Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 223-232

11726

11726 Kung MP, Zhuang ZP, Hou C, Jin LW, Kung HF

Characterization of radioiodinated ligand binding to amyloid beta plaques

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 249-253

11727

11727 Wang YM, Mathis CA, Huang GF, Debnath ML, Holt DP, et al.

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 255-260

11728

11728 Marques MA, Crutcher KA

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 327-337

103

11729

11729 Iqbal K, Alonso AD, El-Akkad E, Gong CX, Haque N, et al.

Alzheimer neurofibrillary degeneration - Therapeutic targets and high- throughput assays

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 20 (3): 425-429

11730

11730 Gilgun-Sherki Y, Melamed E, Offen D

Antioxidant treatment in Alzheimer's disease - Current state

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 21 (1): 1-11

Date / Author / Journal

LCS

GCS

LCR

11731

11731 Levy YS, Merims D, Panet H, Barhum Y, Melamed E, et al.

Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 21 (2): 121-132

11732

11732 Pan WH, Csernus B, Kastin AJ

Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier

JOURNAL OF MOLECULAR NEUROSCIENCE. 2003; 21 (2): 173-184

11733

11733 Tolosa E

Advances in the pharmacological management of Parkinson disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (64): 65-78

101

11734

11734 Youdim MBH

What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 73-88

11735

11735 Jellinger KA

General aspects of neurodegeneration

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 101-144

198

11736

11736 Bosboom JLW, Stoffers D, Wolters EC

The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 185-195

11737

11737 Watts RL, Raiser CD, Stover NP, Cornfeldt ML, Schweikert AW, et al.

Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2003; (65): 215-227

11738

11738 Ciccotosto GD, Barnham KJ, Cherny RA, Masters CL, Bush AI, et al.

Methionine oxidation: Implications for the mechanism of toxicity of the beta-amyloid peptide from Alzheimer's disease

LETTERS IN PEPTIDE SCIENCE. 2003; 10 (5-6): 413-417

11739

11739 Fossella JA, Sommer T, Fan J, Pfaff D, Posner MI

Synaptogenesis and heritable aspects of executive attention

MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2003; 9 (3): 178-183

11740

11740 Mori H, Kosaka S, Arawaka S, Tomiyama T

Distinct functions of tau isoforms in Alzheimer's disease

MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 347-354

Date / Author / Journal

LCS

GCS

LCR

11741

11741 Murakami T, Kawarabayashi T, Matsubara E, Shoji M, Abe K

Molecular pathology of transgenic tau mice

MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 379-382

11742

11742 Dou F, Netzer WJ, Takashima A, Xu HX

Heat shock proteins reduce aggregation and facilitate degradation of tau protein

MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 383-393

11743

11743 Matsubara E, Shoji M, Murakami T, Kawarabayashi T, Abe K

Alzheimer's disease and melatonin

MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 395-398

11744

11744 Chopp M, Li Y

Treatment of stroke with marrow stromal cells

MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA. 2003; 1252: 465-470

11745

11745 Song SM, Jung YK

Ubiquitin and intracellular aggregation - A common pathway of neurodegeneration in chronic dementia?

MOLECULAR MECHANISMS OF PROGRAMMED CELL DEATH. 2003; : 185-193

11746

11746 Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, et al.

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

MOLECULAR PSYCHIATRY. 2003; 8 (3): 343-347

11747

11747 Chesselet MF

Dopamine and Parkinson's disease: is the killer in the house?

MOLECULAR PSYCHIATRY. 2003; 8 (4): 369-370

11748

11748 Sweet RA, Nimponkar VL, Devlin B, Jeste DV

Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype

MOLECULAR PSYCHIATRY. 2003; 8 (4): 383-392

104

11749

11749 Hol EM, Roelofs RF, Moraal E, Sonnemans MAF, Sluijs JA, et al.

Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms

MOLECULAR PSYCHIATRY. 2003; 8 (9): 786-796

11750

11750 Jellinger KA

Neuropathological spectrum of synucleinopathies

MOVEMENT DISORDERS. 2003; 18: S2-S12

Date / Author / Journal

LCS

GCS

LCR

11751

11751 Revesz T, Holton JL

Anatamopathological spectrum of tauopathies

MOVEMENT DISORDERS. 2003; 18: S13-S20

11752

11752 Marti MJ, Tolosa E, Campdelacreu J

Clinical overview of the synucleinopathies

MOVEMENT DISORDERS. 2003; 18: S21-S27

11753

11753 Lees AJ

Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings

MOVEMENT DISORDERS. 2003; 18: S28-S33

11754

11754 Wenning GK, Geser F, Stampfer-Kountchev M, Tison F

Multiple system atrophy: An update

MOVEMENT DISORDERS. 2003; 18: S34-S42

11755

11755 Litvan I

Update on epidemiological aspects of progressive supranuclear palsy

MOVEMENT DISORDERS. 2003; 18: S43-S50

112

11756

11756 Kertesz A

Pick's complex and FTDP-17

MOVEMENT DISORDERS. 2003; 18: S57-S62

11757

11757 Emre M

What causes mental dysfunction in Parkinson's disease?

MOVEMENT DISORDERS. 2003; 18: S63-S71

11758

11758 Uhl GR

Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism

MOVEMENT DISORDERS. 2003; 18: S71-S80

115

11759

11759 Burn DJ, McKeith IG

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

MOVEMENT DISORDERS. 2003; 18: S72-S79

11760

11760 Burn DJ, O'Brien JT

Use of functional imaging in parkinsonism and dementia

MOVEMENT DISORDERS. 2003; 18: S88-S95

Date / Author / Journal

LCS

GCS

LCR

11761

11761 Snowden JS, Neary D

Progressive anomia with preserved oral spelling and automatic speech

NEUROCASE. 2003; 9 (1): 27-43

11762

11762 Cookson MR

Parkin's substrates and the pathways leading to neuronal damage

NEUROMOLECULAR MEDICINE. 2003; 3 (1): 1-13

11763

11763 Trojanowski JQ, Mattson MP

Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 1-5

11764

11764 Hashimoto M, Rockenstein E, Crews L, Masliah E

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 21-35

108

11765

11765 Yancopoulou D, Spillantini MG

Tau protein in familial and sporadic diseases

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 37-48

101

11766

11766 Giasson BI, Lee VMY, Trojanowski JQ

Interactions of amyloidogenic proteins

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 49-58

11767

11767 Smith DH, Uryu K, Saatman KE, Trojanowski JQ, McIntosh TK

Protein accumulation in traumatic brain injury

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 59-72

132

11768

11768 Moore DJ, Dawson VL, Dawson TM

Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 95-108

11769

11769 Schindowski K, Kratzsch T, Peters J, Steiner B, Leutner S, et al.

Impact of aging

NEUROMOLECULAR MEDICINE. 2003; 4 (3): 161-177

11770

11770 Muller T, Voss B, Hellwig K, Przuntek H

Treatment benefit correlates with increase of daily drug costs in Parkinson's disease clinics

NEUROREHABILITATION. 2003; 18 (3): 271-275

Date / Author / Journal

LCS

GCS

LCR

11771

11771 Copray JCVM, Jaarsma D, Kust BM, Bruggeman RWG, Mantingh I, et al.

Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis

NEUROSCIENCE. 2003; 116 (3): 685-694

11772

11772 Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM

Lithium stimulates progenitor proliferation in cultured brain neurons

NEUROSCIENCE. 2003; 117 (1): 55-61

11773

11773 Bussiere T, Gold G, Kovari E, Giannakopoulos P, Bouras C, et al.

Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease

NEUROSCIENCE. 2003; 117 (3): 577-592

11774

11774 Zohar O, Schreiber S, Getslev V, Schwartz JP, Mullins PG, et al.

Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice

NEUROSCIENCE. 2003; 118 (4): 949-955

11775

11775 Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, et al.

Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra- hydropyridine-induced parkinsonism in mice

NEUROSCIENCE. 2003; 118 (4): 985-1002

11776

11776 Sun L, Liu SY, Zhou XW, Wang XC, Liu R, et al.

Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats

NEUROSCIENCE. 2003; 118 (4): 1175-1182

11777

11777 Wu A, Molteni R, Ying Z, Gomez-Pinilla F

A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain- derived neurotrophic factor

NEUROSCIENCE. 2003; 119 (2): 365-375

11778

11778 Van Groen T, Liu L, Ikonen S, Kadish I

Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions

NEUROSCIENCE. 2003; 119 (4): 1185-1197

11779

11779 Pieri M, Gaetti C, Spalloni A, Cavalcanti S, Mercuri N, et al.

alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn superoxide dismutase (Gly(93) -> Ala) mutation

NEUROSCIENCE. 2003; 122 (1): 47-58

11780

11780 Mirnics K, Middleton FA, Pierri JN, Lewis DA, Levitt P

Analysis of brain disorders using DNA microarrays

NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 45-63

131

Date / Author / Journal

11781

Neurodegenerative diseases: Insights from Drosophila and mouse models

NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 85-103

106

11782

11782 Barkats M, Bemelmans A, Brun S, Corti O, Sarkis C, et al.

Gene therapy in the central nervous system

NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 173-186

11783

11783 Kesavapany S, Li BS, Pant HC

Cyclin-dependent kinase 5 in neurofilament function and regulation

NEUROSIGNALS. 2003; 12 (4-5): 252-264

11784

11784 Kheradpezhouh M, Shavali S, Ebadi M

Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells

NEUROSIGNALS. 2003; 12 (6): 315-324

11785

11785 Palomo T, Beninger RJ, Kostrzewa RM, Archer T

Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations

NEUROTOXICITY RESEARCH. 2003; 5 (1-2): 1-26

401

11786

11786 Asanuma M, Miyazaki I, Ogawa N

Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

NEUROTOXICITY RESEARCH. 2003; 5 (3): 165-176

119

114

11787

11787 Andersen JK

Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease

NEUROTOXICITY RESEARCH. 2003; 5 (5): 307-313

11788

11788 Kazuko H, Manabu F, Hisayuki K, Shoji T, Fumiya O

Park 8 - New locus for an autosomal dominant Japanese family

NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS. 2003; : 97-106

11789

11789 MacDonald TJ, Rood BR, Santi MR, Vezina G, Bingaman K, et al.

Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors

ONCOLOGIST. 2003; 8 (2): 174-186

11790

11790 Calne DB

Parkinson's disease over the last 100 years

PARKINSON'S DISEASE. 2003; 91: 1-8

Date / Author / Journal

LCS

GCS

LCR

11791

11791 Przedborski T, Jackson-Lewis V, Vila M, Wu DC, Teismann P, et al.

Free radical and nitric oxide toxicity in Parkinson's disease

PARKINSON'S DISEASE. 2003; 91: 83-94

11792

11792 Gasser T

Overview of the genetics of parkinsonism

PARKINSON'S DISEASE. 2003; 91: 143-152

11793

11793 Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML

Hereditary tauopathies and parkinsonism

PARKINSON'S DISEASE. 2003; 91: 153-163

11794

11794 Golbe LI

alpha-synuclein and Parkinson's disease

PARKINSON'S DISEASE. 2003; 91: 165-174

11795

11795 Facca AG, Koller WC

Differential diagnosis of parkinsonism

PARKINSON'S DISEASE. 2003; 91: 383-396

133

11796

11796 Lim KL, Dawson VL, Dawson TM

The cast of molecular characters in Parkinson's disease - Felons, conspirators, and suspects

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 80-92

11797

11797 Ischiropoulos H

Oxidative modifications of alpha-synuclein

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 93-100

11798

11798 Trojanowski JQ, Lee VMY

Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 107-110

11799

11799 Beal MF

Mitochondria, oxidative damage, and inflammation in Parkinson's disease

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 120-131

206

115

11800

11800 Maguire-Zeiss KA, Federoff HJ

Convergent pathobiologic model of Parkinson's disease

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 152-166

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records